Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Neurofibromatosis 1 × Dosage Forms × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neurofibromatosis 1 1 Lymphoma 1

Interventions

AZD 6244 4 trametinib 1 fludarabine phosphate 1 fludarabine 1 Specimen Handling 1 Injections 1 Dosage Forms 1 Cytarabine 1 Azacitidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05309668 2025-12-18

SPRINKLE

AstraZeneca

Phase 1/2 Active not recruiting

36 enrolled 37 charts

Neurofibromatosis 1

Data powered by HemOnc (CC BY 4.0) Colophon ⚡